Genome Detective Unveils Automated Pathogen Genomics Platform
The cloud-based system aims to address the bottleneck of translating raw genomic data into actionable information for clinical laboratories.
The cloud-based system aims to address the bottleneck of translating raw genomic data into actionable information for clinical laboratories.
ViewsML will present research on its AI-powered virtual immunohistochemistry platform at AACR 2026, highlighting biomarker detection from routine H&E slides without traditional staining.
A multicenter trial published in Clinical Chemistry reports Vitestro’s autonomous phlebotomy system achieved a 94.5% first-stick success rate, with low hemolysis and adverse event rates, in routine clinical settings.
ViewsML will present an AI platform at USCAP 2026 that predicts biomarker expression from standard H&E slides, enabling per-cell spatial analysis without additional staining, according to the company.
The multi-year collaboration includes the deployment of the AISight Dx platform and AI algorithms across the health system’s laboratory network.
Research indicates that apolipoprotein B testing outperforms standard LDL cholesterol tests in predicting risk and guiding therapy.
Increased adoption of flow cytometry and artificial intelligence tools helps clinicians manage the rising number of indeterminate pulmonary nodules.
The test allows for simultaneous detection of multiple viruses on a sample-to-answer platform designed for immunocompromised patients.
The diagnostic tool identifies a specific biological cause of autism with more than 97% predictive accuracy.
n6 has launched the icon16, a 16-well NGS library prep instrument for low-throughput clinical and research labs, featuring per-well real-time amplification control using the company’s AutoNorm technology.
A proof-of-concept study shows that bacteria-metabolized molecules enriched with carbon-13 produce detectable exhaled CO2, enabling rapid infection identification with inexpensive infrared scanners.
Biodesix will present seven abstracts—including two oral sessions—at AACR 2026, highlighting advances in automated myeloid testing, liquid biopsy, and NGS-based cancer monitoring platforms.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
A rapid urine test identified effective UTI antibiotics in an average of 5.85 hours, matching standard lab accuracy in a University of Reading study published in the Journal of Antimicrobial Chemotherapy.